Holen Sie sich die Stockscreener-App
0.557
6.34%
0.0332
Handel nachbörslich:
.56
0.003
+0.54%
Schlusskurs vom Vortag:
$0.5238
Offen:
$0.524006
24-Stunden-Volumen:
156.15K
Relative Volume:
0.08
Marktkapitalisierung:
$2.83M
Einnahmen:
$1.31M
Nettoeinkommen (Verlust:
$-7.47M
KGV:
-0.0772
EPS:
-7.2117
Netto-Cashflow:
$-5.11M
1W Leistung:
-1.15%
1M Leistung:
-44.85%
6M Leistung:
-86.80%
1J Leistung:
+50.34%
1-Tages-Spanne:
$0.4881
$0.568
1-Wochen-Bereich:
$0.4881
$0.5681
52-Wochen-Spanne:
$0.226
$8.90
Scisparc Ltd Stock (SPRC) Company Profile
Compare SPRC vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
0.557 | 2.67M | 1.31M | -7.47M | -5.11M | -7.2117 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.05 | 123.82B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.28 | 81.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
816.95 | 52.00B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.36 | 44.14B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
352.23 | 40.83B | 4.98B | 69.60M | 525.67M | 0.5198 |
Scisparc Ltd Aktie (SPRC) Neueste Nachrichten
SciSparc Amends $10 Million Note Deal, Issues $2 Million Initial Convertible Note - TipRanks
Is SciSparc Ltd. stock safe for conservative investorsShare Buyback & Target Return Focused Stock Picks - mfd.ru
Why SciSparc Ltd. stock remains undervaluedJuly 2025 Rallies & Weekly Market Pulse Alerts - mfd.ru
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
SciSparc Sets Up $10 Million Convertible Note Facility With Warrants - The Globe and Mail
Can SciSparc Ltd. stock outperform in a bear market2025 Trading Recap & Momentum Based Trading Ideas - mfd.ru
Will SciSparc Ltd. stock benefit from infrastructure spendingProduct Launch & High Accuracy Investment Signals - mfd.ru
Will SciSparc Ltd. stock deliver strong dividend growth2025 Trading Volume Trends & Safe Swing Trade Setups - mfd.ru
SciSparc announces resale of 61.21M shares by selling shareholders; shares down - MSN
Should you avoid Star Equity Holdings Inc stock right nowMarket Movement Recap & Community Trade Idea Sharing - baoquankhu1.vn
SciSparc Shareholders Approve February Governance Agenda - TipRanks
Aug Sentiment: How correlated is SciSparc Ltd to the S P5002025 Earnings Impact & Real-Time Chart Pattern Alerts - baoquankhu1.vn
SciSparc subsidiary receives U.S. patent for antibiotic-enhancing cannabinoid technology - Investing.com Nigeria
SciSparc Subsidiary NeuroThera Wins U.S. Patent for Cannabinoid-Based Antimicrobial Resistance Platform - TipRanks
SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome ... - Caledonian Record
SciSparc: NeuroThera Labs Granted U.S. Patent for - GlobeNewswire
Ideas Watch: What is the target price for SciSparc Ltd stockJuly 2025 Highlights & Target Return Focused Picks - baoquankhu1.vn
Aug Fed Impact: What is SciSparc Ltds TAM Total Addressable MarketMarket Trend Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Entry Recap: Is SciSparc Ltd backed by strong institutional buyingJuly 2025 Update & AI Enhanced Execution Alerts - baoquankhu1.vn
Market Trends: Is SciSparc Ltd part of any ETFWeekly Risk Summary & Verified Chart Pattern Trade Signals - baoquankhu1.vn
SciSparc acquires MUSE system IP portfolio to enter GERD device market - Investing.com Australia
SciSparc acquires MUSE system IP portfolio to enter GERD device market By Investing.com - Investing.com South Africa
SciSparc Closes Acquisition of Xylo GERD Device IP, Moves to Immediate Commercialization - TipRanks
SciSparc Acquires Innovative GERD Device IP Portfolio from Xylo Technologies to Target Multi-Billion Dollar Market - Quiver Quantitative
SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate ... - Caledonian Record
SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization - GlobeNewswire
Big Money Moves: Is Funko Inc part of any ETFJuly 2025 Chart Watch & Fast Momentum Entry Tips - baoquankhu1.vn
Aug Wrap: Should you buy the dip on Rithm Acquisition Corp Debt Equity Composite UnitsWeekly Trade Analysis & Community Consensus Trade Alerts - baoquankhu1.vn
Critical Analysis: SciSparc (NASDAQ:SPRC) and ARS Pharmaceuticals (NASDAQ:SPRY) - Defense World
SciSparc receives Nasdaq notice over stockholders’ equity shortfall - MSN
Gainers Report: Is SciSparc Ltd backed by strong institutional buyingDollar Strength & AI Driven Price Predictions - baoquankhu1.vn
SPRC Stock Price, Forecast & Analysis | SCISPARC LTD (NASDAQ:SPRC) - Chartmill
Short Covering: What drives SciSparc Ltd.’s stock price2025 Key Lessons & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Form 424B5 SciSparc Ltd. - StreetInsider
SciSparc Receives Nasdaq Notice Over Minimum Stockholders’ Equity Non-Compliance - The Globe and Mail
SciSparc Launches $766,170 Registered Direct Share Offering - The Globe and Mail
SciSparc to acquire MUSE endoscopic system patents from Xylo By Investing.com - Investing.com Nigeria
SciSparc to Acquire Endoscopic Device Patents Targeting $3B Market - Meyka
SciSparc Moves Into Endoscopy With Strategic Patent Deal - Sahm
SciSparc Ltd. (SPRC) stock: dips nearly 12% as company unveils strategic MUSE™ endoscopic technology acquisition - parameter.io
SciSparc Faces Nasdaq Non-Compliance Challenge Over Stockholders’ Equity - StocksToTrade
SciSparc to acquire MUSE endoscopic system patents from Xylo - Investing.com
SciSparc Faces Nasdaq Noncompliance: Struggles Loom - StocksToTrade
SciSparc Signs Agreement To Acquire Patent Portfolio For Endoscopic Technologies; Stock Soars - Nasdaq
SciSparc Subsidiary to Acquire Endoscopic Patents of Xylo Technologies in All-Stock Deal - marketscreener.com
SciSparc to Acquire Xylo GERD Device IP in Share-Based Deal, Targeting Global Endoscope Market - TipRanks
SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity - The Manila Times
SciSparc receives Nasdaq non-compliance notice for stockholders’ equity By Investing.com - Investing.com Nigeria
SciSparc receives Nasdaq non-compliance notice for stockholders’ equity - Investing.com
Finanzdaten der Scisparc Ltd-Aktie (SPRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.52%
1.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):